Cosmo Pharmaceuticals N.V. (CMOPF)
OTCMKTS
· Delayed Price · Currency is USD
55.00
-7.80 (-12.42%)
At close: Apr 10, 2025
Cosmo Pharmaceuticals Employees
Cosmo Pharmaceuticals had 322 employees as of December 31, 2024. The number of employees decreased by 3 or -0.98% compared to the previous year.
Employees
322
Change (1Y)
-3
Growth (1Y)
-0.98%
Revenue / Employee
$857,785
Profits / Employee
$428,384
Market Cap
902.30M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
SS Innovations International | 378 |
Endo Inc. | 3,116 |
Elite Pharmaceuticals | 64 |
Northwest Biotherapeutics | 25 |
Glass House Brands | 374 |
CytoDyn | 9 |
American Oncology Network | 1,914 |
Longduoduo Company | 49 |
Cosmo Pharmaceuticals News
- 23 days ago - Cosmo Pharmaceuticals ernennt neuen Chief Legal Counsel - Cash
- 4 weeks ago - Cosmo Pharmaceuticals reports FY results - Seeking Alpha
- 6 weeks ago - Cosmo Pharmaceuticals NV (CMOPF) (FY 2024) Earnings Call Highlights: Record Revenues and ... - GuruFocus
- 6 weeks ago - Full Year 2024 Cosmo Pharmaceuticals NV Earnings Call Transcript - GuruFocus
- 3 months ago - Cosmo Pharmaceuticals estimates 186% Y/Y growth in 2024 revenue - Seeking Alpha
- 6 months ago - Cosmo Pharmaceuticals gets new finance chief - Seeking Alpha